Evidence map›Paper›PMID 24782309›Full record

ArticleThe Journal of biological chemistry2014

The protein synthesis inhibitor blasticidin s enters mammalian cells via leucine-rich repeat-containing protein 8D.

Clarissa C Lee, Elizaveta Freinkman, David M Sabatini, Hidde L Ploegh

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed
3.3field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 77 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Ion Channel Involvement in Tumor Drug Resistance.Journal of personalized medicine · 2022
    Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Clarissa C LeeFrom the Whitehead Institute for Biomedical Research, Cambridge, Massachusetts 02142, the Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139.
Elizaveta FreinkmanFrom the Whitehead Institute for Biomedical Research, Cambridge, Massachusetts 02142.
David M SabatiniFrom the Whitehead Institute for Biomedical Research, Cambridge, Massachusetts 02142, the Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, the David H. Koch Institute for Integrative Cancer Research at Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, the Broad Institute, Cambridge, Massachusetts 02142, and the Howard Hughes Medical Institute, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139.
Hidde L PloeghFrom the Whitehead Institute for Biomedical Research, Cambridge, Massachusetts 02142, the Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, ploegh@wi.mit.edu.
Whitehead Institute for Biomedical Research · USBroad Institute · US

Funding

VIRUS PRODUCTION COREP30CA014051 · NCI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI Michael Birnbaum · 1985 to 2026
$93.9M
NCI NIH HHS P30 CA014051
6 · The paper itself

Abstract

Leucine-rich repeat-containing 8 (LRRC8) proteins have been identified as putative receptors involved in lymphocyte development and adipocyte differentiation. They remain poorly characterized, and no specific function has been assigned to them. There is no consensus on how this family of proteins might function because homology searches suggest that members of the LRRC8 family act not as plasma membrane receptors, but rather as channels that mediate cell-cell signaling. Here we provide experimental evidence that supports a role for LRRC8s in the transport of small molecules. We show that LRRC8D is a mammalian protein required for the import of the antibiotic blasticidin S. We characterize localization and topology of LRRC8A and LRRC8D and demonstrate that LRRC8D interacts with LRRC8A, LRRC8B, and LRRC8C. Given the suggested involvement in solute transport, our results support a model in which LRRC8s form one or more complexes that may mediate cell-cell communication by transporting small solutes.

Indexed as

Anti-Bacterial AgentsBiological TransportCell Line, TumorHumansMembrane ProteinsNucleosidesProtein BindingProtein Synthesis InhibitorsAnti-Bacterial Agentsblasticidin SLRRC8A protein, humanLRRC8A protein, mouseMembrane ProteinsNucleosidesProtein Synthesis InhibitorsAntibioticsBlasticidin SDrug TransportGene KnockoutLRRC8DMass Spectrometry (MS)Membrane ProteinMetabolomicsProtein-Protein InteractionSomatic Cell Genetics

Identifiers

PMID24782309
PMCPMC4059153
OpenAlexW1975272789

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.